ReviewDermatologie (Heidelberg, Germany)2026
[Management of genital herpes].
Review in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [25/m with painful pustules and ulcerations in the genital area : Preparation for the medical specialist examination: part 72].Dermatologie (Heidelberg, Germany) · 2026Article
- Maternal-Fetal Implications of Herpes Virus Infection: An Updated Review.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genital herpes, caused by the herpes simplex virus (HSV), is one of the most common sexually transmitted infections worldwide and the leading cause of genital ulcers. The virus is globally primarily transmitted by HSV‑2, although HSV‑1, especially in Europe, is increasingly recognized as a cause of genital first-episode infections. Many infections are asymptomatic, making unnoticed viral shedding the most frequent mode of transmission. Infection is preferably confirmed using polymerase chain reaction (PCR) from intact vesicles. Early and comprehensive patient education regarding symptoms, treatment options, and potential implications for sexual health is of great importance. Antiviral therapy, preferentially with acyclovir and valacyclovir can reduce both the severity and duration of the infection. For recurrent infections, suppressive antiviral treatment is recommended to decrease the frequency of recurrences and the transmission risk. Specific recommendations should be followed for special patient groups such as pregnant women and immunocompromised individuals.
Indexed as
Identifiers
41686237What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.